Medulloblastoma is the most common malignant solid childhood tumor. These tumors arise from precursor cells of the developing cerebellum, a brain region which undergoes rapid expansion after birth. Current treatments for these tumors include surgery, radiation, and chemotherapy, which cause lasting physical, cognitive, and psychological effects. Thus, development of more optimal treatments is of great importance. Links between neurodevelopmentally critical signaling pathways (such as those activated by Sonic hedgehog, Notch, wnt, and insulin-like growth factor) and medulloblastoma formation or maintenance have been made. Major projects in the lab focus on neural precursor proliferation regulation by these signaling pathways. Our efforts include investigation of how such pathways interact with each other and with the cell cycle regulatory machinery; characterization of specific pathway targets; functional analysis of the pathways' effectors; and genetic manipulation of these pathways and their targets in mice to better understand brain development, cancer, and CNS pathologies.